Abstract:Crimean-Congo Hemorrhagic Fever virus (CCHFV) is a tick-borne pathogen that causes severe acute fever disease in humans and requires a biosafety level 4 laboratory for handling. Hazara virus (HAZV), belonging to the same virus genus as CCHFV, does not exhibit pathogenesis in humans. To investigate host RNA-binding proteins (RBPs) that regulate CCHFV replication, we generated a series of mutant RAW264.7 cells by CRISPR/Cas9 system and these cells were infected with HAZV. The viral titers in the supernatant of these cells was investigated, and HuR (ELAVL1) was identified. HuR KO RAW264.7 cells reduced HAZV replication. HuR is an RBP that enhances mRNA stability by binding to adenyl-uridine (AU)-rich regions in their 3′ non-coding region (NCR). HuR regulates innate immune response by binding to host mRNAs of signaling molecules. The expression of cytokine genes such as Ifnb , Il6 , and Tnf was reduced in HuR KO cells after HAZV infection. Although HuR supports the innate immune response during HAZV infection, we found that innate immune activation by HAZV infection did not affect its replication. We then investigated whether HuR regulates HAZV genome RNA stability. HAZV RNA genome was precipitated with an anti-HuR antibody, and HAZV genome RNA stability was lowered in HuR KO cells. We found that HuR associated with HAZV RNA and stabilized it to enhance HAZV replication. Furthermore, HuR-deficiency reduced CCHFV minigenome replication. CCHFV is a negative-strand RNA virus and positive-strand RNA is produced during replication. HuR was associated with positive-strand RNA rather than negative-strand RNA, and AU-rich region in 3'-NCR of S segment was responsible for immunoprecipitation with anti-HuR antibody and minigenome replication. Additionally, HuR inhibitor treatment reduced CCHFV minigenome replication. Our results indicate that HuR aids replication of the CCHFV minigenome by associating with the AU-rich region in the 3′-NCR. Crimean-Congo Hemorrhagic Fever virus (CCHFV) is a tick-borne pathogen that causes severe acute fever disease in humans and requires a biosafety level 4 laboratory for handling. Hazara virus (HAZV), the same genus of CCHFV, has been used as a model virus to reveal the molecular mechanism of CCHFV infection. To investigate host factors for CCHFV replication, we generated a series of mutant RAW264.7 cells and conducted screening for host genes that regulate the replication of HAZV, identifying HuR (ELAVL1). HuR is an RNA-binding protein (RBP) that enhances mRNA stability by binding to its 3′ non-coding region (NCR). We found that HuR is associated with the CCHFV RNA stability by binding to its 3'-NCR, and the minigenome assay showed that CCHFV replication is supported by HuR. HuR inhibitor treatment also reduced CCHFV minigenome replication. These findings present a possible starting point for the future development of antiviral drug targeting host RBPs. Combination treatment with RdRp and RBP inhibitors may be a potential therapeutic strategy in the future.

HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding

HuR Interacts with Human Immunodeficiency Virus Type 1 Reverse Transcriptase, and Modulates Reverse Transcription in Infected Cells

Targeting the RNA-binding protein HuR in cancer.

An RNA-immunoprecipitation via CRISPR/dCas13 reveals an interaction between the SARS-CoV-2 5'UTR RNA and the process of human lipid metabolism

Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis

The RNA-binding protein HuR in human cancer: A friend or foe?

Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion

The differential effect of SARS-COV-2 NSP1 on mRNA translation and stability reveals new insights linking ribosome recruitment, codon usage and virus evolution

HuR (ELAVL1) regulates the CCHFV minigenome and HAZV replication by associating with viral genomic RNA

Host-like RNA Elements Regulate Virus Translation

A genome-wide CRISPR screen identifies HuR as a regulator of apoptosis induced by dsRNA and virus

SARS-CoV-2 Nsp1 Suppresses Host but Not Viral Translation Through a Bipartite Mechanism

A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation

The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.

In Vivo Structural Characterization of the SARS-CoV-2 RNA Genome Identifies Host Proteins Vulnerable to Repurposed Drugs.

SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression

RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5'-untranslated region

High-sensitivity profiling of SARS-CoV-2 noncoding region–host protein interactome reveals the potential regulatory role of negative-sense viral RNA

SARS-CoV-2 Nsp1 cooperates with initiation factors EIF1 and 1A to selectively enhance translation of viral RNA

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics

Multiple Functions of HuR in Urinary Tumors